MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical ...

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...
Morning Overview on MSN

Brazilian arthritis folk cure tested, and the data looks promising

For generations, Brazilians have turned to a colorful garden plant to soothe aching joints, trusting experience long before ...
MedPage Today on MSN

Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...
Stacker on MSNOpinion

Comparing 12 common rheumatoid arthritis prescriptions

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
Edmonton Journal on MSN

Edmonton's beloved elephant, Lucy, given clean bill of health after annual checkup

One of Edmonton’s most famous geriatric residents, Lucy the Elephant, has been given a clean bill of health after undergoing ...